PortfoliosLab logoPortfoliosLab logo
ACRS vs. BFLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ACRS vs. BFLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aclaris Therapeutics, Inc. (ACRS) and Butterfly Network, Inc. (BFLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ACRS achieves a 72.76% return, which is significantly lower than BFLY's 87.11% return.


ACRS

1D
-2.26%
1M
-6.47%
6M
48.15%
YTD
72.76%
1Y
239.87%
3Y*
-19.07%
5Y*
-19.02%
10Y*
-12.11%
ALL TIME*
-7.40%

BFLY

1D
-12.97%
1M
-7.42%
6M
79.55%
YTD
87.11%
1Y
407.86%
3Y*
40.56%
5Y*
-7.92%
10Y*
ALL TIME*
-5.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$8.58M$9.53M$8.25M
$49.93M$59.25M$54.27M

ACRS vs. BFLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ACRS
Aclaris Therapeutics, Inc.
72.76%21.37%136.19%-93.33%8.32%124.73%226.77%
BFLY
Butterfly Network, Inc.
87.11%21.79%188.89%-56.10%-63.23%-66.20%94.78%

Correlation

The correlation between ACRS and BFLY is 0.23, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.23

Correlation (3Y)
Balances recent behavior with more history.

0.27

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.32

Correlation (All Time)
Calculated using the full available price history since Jul 13, 2020

0.30

Fundamentals

Market Cap

ACRS:

$726.25M

BFLY:

$1.89B

EPS

ACRS:

-$0.56

BFLY:

-$0.29

PS Ratio

ACRS:

77.50

BFLY:

16.76

PB Ratio

ACRS:

4.66

BFLY:

9.84

Total Revenue (TTM)

ACRS:

$8.37M

BFLY:

$108.56M

Gross Profit (TTM)

ACRS:

$6.39M

BFLY:

$55.45M

EBITDA (TTM)

ACRS:

-$73.08M

BFLY:

-$69.02M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ACRS vs. BFLY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ACRS
ACRS Risk / Return Rank: 9696
Overall Rank
ACRS Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
ACRS Sortino Ratio Rank: 9696
Sortino Ratio Rank
ACRS Omega Ratio Rank: 9494
Omega Ratio Rank
ACRS Calmar Ratio Rank: 9797
Calmar Ratio Rank
ACRS Martin Ratio Rank: 9797
Martin Ratio Rank

BFLY
BFLY Risk / Return Rank: 9696
Overall Rank
BFLY Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
BFLY Sortino Ratio Rank: 9595
Sortino Ratio Rank
BFLY Omega Ratio Rank: 9393
Omega Ratio Rank
BFLY Calmar Ratio Rank: 9898
Calmar Ratio Rank
BFLY Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ACRS vs. BFLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aclaris Therapeutics, Inc. (ACRS) and Butterfly Network, Inc. (BFLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ACRSBFLYDifference
Sharpe ratioReturn per unit of total volatility

-0.03

Sortino ratioReturn per unit of downside risk

+0.29

Omega ratioGain probability vs. loss probability

1.45

1.42

+0.03

Calmar ratioReturn relative to maximum drawdown

6.59

7.84

-1.24

Martin ratioReturn relative to average drawdown

18.05

19.14

-1.08

ACRS vs. BFLY - Sharpe Ratio Comparison

The current ACRS Sharpe Ratio is 2.50, which is comparable to the BFLY Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of ACRS and BFLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ACRS vs. BFLY - Drawdown Comparison

The maximum ACRS drawdown since its inception was -98.05%, roughly equal to the maximum BFLY drawdown of -97.40%. Use the drawdown chart below to compare losses from any high point for ACRS and BFLY.


Loading charts...

Drawdown Indicators


ACRSBFLYDifference

Max Drawdown

Largest peak-to-trough decline

-98.05%

-97.40%

-0.65%

Max Drawdown (1Y)

Largest decline over 1 year

-36.64%

-40.61%

+3.97%

Max Drawdown (3Y)

Largest decline over 3 years

-93.45%

-72.41%

-21.04%

Max Drawdown (5Y)

Largest decline over 5 years

-96.57%

-94.68%

-1.89%

Max Drawdown (10Y)

Largest decline over 10 years

-98.05%

Current Drawdown

Current decline from peak

-84.24%

-73.80%

-10.44%

Average Drawdown

Average peak-to-trough decline

-63.91%

-75.88%

+11.97%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.35%

17.29%

-3.94%

Volatility

ACRS vs. BFLY - Volatility Comparison

The current volatility for Aclaris Therapeutics, Inc. (ACRS) is 14.22%, while Butterfly Network, Inc. (BFLY) has a volatility of 28.54%. This indicates that ACRS experiences smaller price fluctuations and is considered to be less risky than BFLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ACRSBFLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.22%

28.54%

-14.32%

Volatility (6M)

Calculated over the trailing 6-month period

44.25%

88.73%

-44.48%

Volatility (1Y)

Calculated over the trailing 1-year period

96.44%

125.63%

-29.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.32%

102.15%

-9.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

110.39%

97.82%

+12.57%

Dividends

ACRS vs. BFLY - Dividend Comparison

Neither ACRS nor BFLY has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ACRS vs. BFLY - Financials Comparison

This section allows you to compare key financial metrics between Aclaris Therapeutics, Inc. and Butterfly Network, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ACRS and BFLY have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BFLY has higher volatility (28.54%) compared to ACRS (14.22%). In terms of maximum drawdown, ACRS dropped -98.05% vs BFLY's -97.40%.

BFLY currently has the higher Sharpe Ratio (2.54 vs 2.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ACRS and BFLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer